APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nifedipine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174017010330 December 2025194 pages

Choose your research edition.

Industry ResearchNifedipine API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine API Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine API Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nifedipine API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine API include Bayer AG, Cipla Ltd, Delmar Chemicals Inc., Dipharma Francis S.r.l, Moehs Iberica S.L., Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Teva Pharmaceuticals and Siyao Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine API market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine API Segment by Company

Bayer AG

Cipla Ltd

Delmar Chemicals Inc.

Dipharma Francis S.r.l

Moehs Iberica S.L.

Sumika Fine Chemicals Co. Ltd.

Tecoland Corp

Teva Pharmaceuticals

Siyao Pharmaceuticals

Xiyue Pharmaceutical

Zhong'an Pharmaceutical

Yantai Luyin Pharmaceutical

Qingyang Pharmaceutical

Nifedipine API Segment by Type

98% Nifedipine API

99% Nifedipine API

99.9% Nifedipine API

Nifedipine API Segment by Application

Nifedipine Controlled Release Tablets

Nifedipine Extended Release Tablets

Nifedipine API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Nifedipine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Nifedipine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Nifedipine API Industry Trends Table 2. Nifedipine API Industry Drivers Table 3. Nifedipine API Industry Opportunities and Challenges Table 4. Nifedipine API Industry Restraints Table 5. Global Nifedipine API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nifedipine API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Nifedipine API Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Nifedipine API Sales Market Share by Manufacturers Table 9. Global Nifedipine API Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Nifedipine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nifedipine API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nifedipine API Manufacturers, Product Type & Application Table 13. Global Nifedipine API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 98% Nifedipine API Table 17. Major Manufacturers of 99% Nifedipine API Table 18. Major Manufacturers of 99.9% Nifedipine API Table 19. Global Nifedipine API Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 20. Global Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 21. Global Nifedipine API Sales by Type (2027-2032) & (K Tons) Table 22. Global Nifedipine API Sales Market Share by Type (2021-2026) Table 23. Global Nifedipine API Sales Market Share by Type (2027-2032) Table 24. Global Nifedipine API Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 25. Global Nifedipine API Revenue by Type (2021-2026) & (K Tons) Table 26. Global Nifedipine API Revenue by Type (2027-2032) & (K Tons) Table 27. Global Nifedipine API Revenue Market Share by Type (2021-2026) Table 28. Global Nifedipine API Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Nifedipine Controlled Release Tablets Table 30. Major Manufacturers of Nifedipine Extended Release Tablets Table 31. Global Nifedipine API Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 32. Global Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 33. Global Nifedipine API Sales by Application (2027-2032) & (K Tons) Table 34. Global Nifedipine API Sales Market Share by Application (2021-2026) Table 35. Global Nifedipine API Sales Market Share by Application (2027-2032) Table 36. Global Nifedipine API Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 37. Global Nifedipine API Revenue by Application (2021-2026) & (K Tons) Table 38. Global Nifedipine API Revenue by Application (2027-2032) & (K Tons) Table 39. Global Nifedipine API Revenue Market Share by Application (2021-2026) Table 40. Global Nifedipine API Revenue Market Share by Application (2027-2032) Table 41. Global Nifedipine API Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 42. Global Nifedipine API Sales by Region (2021-2026) & (K Tons) Table 43. Global Nifedipine API Sales Market Share by Region (2021-2026) Table 44. Global Nifedipine API Sales Forecasted by Region (2027-2032) & (K Tons) Table 45. Global Nifedipine API Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 47. North America Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 48. North America Nifedipine API Sales by Country (2027-2032) & (K Tons) Table 49. Europe Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 50. Europe Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 51. Europe Nifedipine API Sales by Country (2027-2032) & (K Tons) Table 52. Asia Pacific Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 53. Asia Pacific Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 54. Asia Pacific Nifedipine API Sales by Country (2027-2032) & (K Tons) Table 55. South America, Middle East and Africa Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. South America, Middle East and Africa Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 57. South America, Middle East and Africa Nifedipine API Sales by Country (2027-2032) & (K Tons) Table 58. Global Nifedipine API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Nifedipine API Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Nifedipine API Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Nifedipine API Revenue Market Share by Region (2021-2026) Table 62. Global Nifedipine API Revenue Market Share by Region (2027-2032) Table 63. Bayer AG Company Information Table 64. Bayer AG Business Overview Table 65. Bayer AG Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer AG Nifedipine API Product Portfolio Table 67. Bayer AG Recent Development Table 68. Cipla Ltd Company Information Table 69. Cipla Ltd Business Overview Table 70. Cipla Ltd Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cipla Ltd Nifedipine API Product Portfolio Table 72. Cipla Ltd Recent Development Table 73. Delmar Chemicals Inc. Company Information Table 74. Delmar Chemicals Inc. Business Overview Table 75. Delmar Chemicals Inc. Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Delmar Chemicals Inc. Nifedipine API Product Portfolio Table 77. Delmar Chemicals Inc. Recent Development Table 78. Dipharma Francis S.r.l Company Information Table 79. Dipharma Francis S.r.l Business Overview Table 80. Dipharma Francis S.r.l Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Dipharma Francis S.r.l Nifedipine API Product Portfolio Table 82. Dipharma Francis S.r.l Recent Development Table 83. Moehs Iberica S.L. Company Information Table 84. Moehs Iberica S.L. Business Overview Table 85. Moehs Iberica S.L. Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Moehs Iberica S.L. Nifedipine API Product Portfolio Table 87. Moehs Iberica S.L. Recent Development Table 88. Sumika Fine Chemicals Co. Ltd. Company Information Table 89. Sumika Fine Chemicals Co. Ltd. Business Overview Table 90. Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio Table 92. Sumika Fine Chemicals Co. Ltd. Recent Development Table 93. Tecoland Corp Company Information Table 94. Tecoland Corp Business Overview Table 95. Tecoland Corp Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Tecoland Corp Nifedipine API Product Portfolio Table 97. Tecoland Corp Recent Development Table 98. Teva Pharmaceuticals Company Information Table 99. Teva Pharmaceuticals Business Overview Table 100. Teva Pharmaceuticals Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teva Pharmaceuticals Nifedipine API Product Portfolio Table 102. Teva Pharmaceuticals Recent Development Table 103. Siyao Pharmaceuticals Company Information Table 104. Siyao Pharmaceuticals Business Overview Table 105. Siyao Pharmaceuticals Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Siyao Pharmaceuticals Nifedipine API Product Portfolio Table 107. Siyao Pharmaceuticals Recent Development Table 108. Xiyue Pharmaceutical Company Information Table 109. Xiyue Pharmaceutical Business Overview Table 110. Xiyue Pharmaceutical Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Xiyue Pharmaceutical Nifedipine API Product Portfolio Table 112. Xiyue Pharmaceutical Recent Development Table 113. Zhong'an Pharmaceutical Company Information Table 114. Zhong'an Pharmaceutical Business Overview Table 115. Zhong'an Pharmaceutical Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Zhong'an Pharmaceutical Nifedipine API Product Portfolio Table 117. Zhong'an Pharmaceutical Recent Development Table 118. Yantai Luyin Pharmaceutical Company Information Table 119. Yantai Luyin Pharmaceutical Business Overview Table 120. Yantai Luyin Pharmaceutical Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio Table 122. Yantai Luyin Pharmaceutical Recent Development Table 123. Qingyang Pharmaceutical Company Information Table 124. Qingyang Pharmaceutical Business Overview Table 125. Qingyang Pharmaceutical Nifedipine API Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Qingyang Pharmaceutical Nifedipine API Product Portfolio Table 127. Qingyang Pharmaceutical Recent Development Table 128. Key Raw Materials Table 129. Raw Materials Key Suppliers Table 130. Nifedipine API Distributors List Table 131. Nifedipine API Customers List Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Nifedipine API Product Image Figure 2. Global Nifedipine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine API Sales (2021-2032) & (K Tons) Figure 5. Global Nifedipine API Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Nifedipine API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 98% Nifedipine API Image Figure 9. 99% Nifedipine API Image Figure 10. 99.9% Nifedipine API Image Figure 11. Global Nifedipine API Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 12. Global Nifedipine API Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nifedipine API Sales Market Share by Type (2021-2032) Figure 14. Global Nifedipine API Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 15. Global Nifedipine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Nifedipine API Revenue Market Share by Type (2021-2032) Figure 17. Nifedipine Controlled Release Tablets Image Figure 18. Nifedipine Extended Release Tablets Image Figure 19. Global Nifedipine API Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 20. Global Nifedipine API Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Nifedipine API Sales Market Share by Application (2021-2032) Figure 22. Global Nifedipine API Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 23. Global Nifedipine API Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Nifedipine API Revenue Market Share by Application (2021-2032) Figure 25. North America Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 26. North America Nifedipine API Sales Market Share by Country (2021-2032) Figure 27. U.S. Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 28. Canada Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Mexico Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Europe Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Nifedipine API Sales Market Share by Country (2021-2032) Figure 32. Germany Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 33. France Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. U.K. Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. Italy Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Netherlands Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Asia Pacific Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Nifedipine API Sales Market Share by Country (2021-2032) Figure 39. China Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. Japan Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. South Korea Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. Southeast Asia Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. India Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. Australia Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. South America, Middle East and Africa Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Nifedipine API Sales Market Share by Country (2021-2032) Figure 47. Brazil Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. South Africa Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. Saudi Arabia Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Turkey Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Argentina Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. UAE Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. Egypt Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Chile Nifedipine API Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Global Nifedipine API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Nifedipine API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Nifedipine API Revenue (2021-2032) & (US$ Million) Figure 58. North America Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Nifedipine API Revenue (2021-2032) & (US$ Million) Figure 60. Europe Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Nifedipine API Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Nifedipine API Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Nifedipine API Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Nifedipine API Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 98% Nifedipine API
  • 99% Nifedipine API
  • 99.9% Nifedipine API
Applications
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Release Tablets
Companies covered
  • Bayer AG
  • Cipla Ltd
  • Delmar Chemicals Inc.
  • Dipharma Francis S.r.l
  • Moehs Iberica S.L.
  • Sumika Fine Chemicals Co. Ltd.
  • Tecoland Corp
  • Teva Pharmaceuticals
  • Siyao Pharmaceuticals
  • Xiyue Pharmaceutical
  • Zhong'an Pharmaceutical
  • Yantai Luyin Pharmaceutical
  • Qingyang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Nifedipine API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Nifedipine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Nifedipine API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Nifedipine API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Nifedipine API Market Dynamics
  1. 2.1 Nifedipine API Industry Trends
  2. 2.2 Nifedipine API Industry Drivers
  3. 2.3 Nifedipine API Industry Opportunities and Challenges
  4. 2.4 Nifedipine API Industry Restraints
3 Nifedipine API Market by Manufacturers
  1. 3.1 Global Nifedipine API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Nifedipine API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Nifedipine API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Nifedipine API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nifedipine API Manufacturers, Product Type & Application
  7. 3.7 Global Nifedipine API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine API Tier 1, Tier 2, and Tier 3
4 Nifedipine API Market by Type
  1. 4.1 Nifedipine API Type Introduction
  2. 4.1.1 98% Nifedipine API
  3. 4.1.2 99% Nifedipine API
  4. 4.1.3 99.9% Nifedipine API
  5. 4.2 Global Nifedipine API Sales by Type
  6. 4.2.1 Global Nifedipine API Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nifedipine API Sales by Type (2021-2032)
  8. 4.2.3 Global Nifedipine API Sales Market Share by Type (2021-2032)
  9. 4.3 Global Nifedipine API Revenue by Type
  10. 4.3.1 Global Nifedipine API Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nifedipine API Revenue by Type (2021-2032)
  12. 4.3.3 Global Nifedipine API Revenue Market Share by Type (2021-2032)
5 Nifedipine API Market by Application
  1. 5.1 Nifedipine API Application Introduction
  2. 5.1.1 Nifedipine Controlled Release Tablets
  3. 5.1.2 Nifedipine Extended Release Tablets
  4. 5.2 Global Nifedipine API Sales by Application
  5. 5.2.1 Global Nifedipine API Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Nifedipine API Sales by Application (2021-2032)
  7. 5.2.3 Global Nifedipine API Sales Market Share by Application (2021-2032)
  8. 5.3 Global Nifedipine API Revenue by Application
  9. 5.3.1 Global Nifedipine API Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Nifedipine API Revenue by Application (2021-2032)
  11. 5.3.3 Global Nifedipine API Revenue Market Share by Application (2021-2032)
6 Global Nifedipine API Sales by Region
  1. 6.1 Global Nifedipine API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine API Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine API Sales by Region (2021-2026)
  4. 6.2.2 Global Nifedipine API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Nifedipine API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Nifedipine API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Nifedipine API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Nifedipine API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Nifedipine API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Nifedipine API Revenue by Region
  1. 7.1 Global Nifedipine API Revenue by Region
  2. 7.1.1 Global Nifedipine API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Nifedipine API Revenue by Region (2021-2026)
  4. 7.1.3 Global Nifedipine API Revenue by Region (2027-2032)
  5. 7.1.4 Global Nifedipine API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Nifedipine API Revenue (2021-2032)
  8. 7.2.2 North America Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Nifedipine API Revenue (2021-2032)
  11. 7.3.2 Europe Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Nifedipine API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Nifedipine API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Nifedipine API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Nifedipine API Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Cipla Ltd
  8. 8.2.1 Cipla Ltd Company Information
  9. 8.2.2 Cipla Ltd Business Overview
  10. 8.2.3 Cipla Ltd Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Ltd Nifedipine API Product Portfolio
  12. 8.2.5 Cipla Ltd Recent Developments
  13. 8.3 Delmar Chemicals Inc.
  14. 8.3.1 Delmar Chemicals Inc. Company Information
  15. 8.3.2 Delmar Chemicals Inc. Business Overview
  16. 8.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Delmar Chemicals Inc. Nifedipine API Product Portfolio
  18. 8.3.5 Delmar Chemicals Inc. Recent Developments
  19. 8.4 Dipharma Francis S.r.l
  20. 8.4.1 Dipharma Francis S.r.l Company Information
  21. 8.4.2 Dipharma Francis S.r.l Business Overview
  22. 8.4.3 Dipharma Francis S.r.l Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Dipharma Francis S.r.l Nifedipine API Product Portfolio
  24. 8.4.5 Dipharma Francis S.r.l Recent Developments
  25. 8.5 Moehs Iberica S.L.
  26. 8.5.1 Moehs Iberica S.L. Company Information
  27. 8.5.2 Moehs Iberica S.L. Business Overview
  28. 8.5.3 Moehs Iberica S.L. Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Moehs Iberica S.L. Nifedipine API Product Portfolio
  30. 8.5.5 Moehs Iberica S.L. Recent Developments
  31. 8.6 Sumika Fine Chemicals Co. Ltd.
  32. 8.6.1 Sumika Fine Chemicals Co. Ltd. Company Information
  33. 8.6.2 Sumika Fine Chemicals Co. Ltd. Business Overview
  34. 8.6.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio
  36. 8.6.5 Sumika Fine Chemicals Co. Ltd. Recent Developments
  37. 8.7 Tecoland Corp
  38. 8.7.1 Tecoland Corp Company Information
  39. 8.7.2 Tecoland Corp Business Overview
  40. 8.7.3 Tecoland Corp Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Tecoland Corp Nifedipine API Product Portfolio
  42. 8.7.5 Tecoland Corp Recent Developments
  43. 8.8 Teva Pharmaceuticals
  44. 8.8.1 Teva Pharmaceuticals Company Information
  45. 8.8.2 Teva Pharmaceuticals Business Overview
  46. 8.8.3 Teva Pharmaceuticals Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceuticals Nifedipine API Product Portfolio
  48. 8.8.5 Teva Pharmaceuticals Recent Developments
  49. 8.9 Siyao Pharmaceuticals
  50. 8.9.1 Siyao Pharmaceuticals Company Information
  51. 8.9.2 Siyao Pharmaceuticals Business Overview
  52. 8.9.3 Siyao Pharmaceuticals Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Siyao Pharmaceuticals Nifedipine API Product Portfolio
  54. 8.9.5 Siyao Pharmaceuticals Recent Developments
  55. 8.10 Xiyue Pharmaceutical
  56. 8.10.1 Xiyue Pharmaceutical Company Information
  57. 8.10.2 Xiyue Pharmaceutical Business Overview
  58. 8.10.3 Xiyue Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xiyue Pharmaceutical Nifedipine API Product Portfolio
  60. 8.10.5 Xiyue Pharmaceutical Recent Developments
  61. 8.11 Zhong'an Pharmaceutical
  62. 8.11.1 Zhong'an Pharmaceutical Company Information
  63. 8.11.2 Zhong'an Pharmaceutical Business Overview
  64. 8.11.3 Zhong'an Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zhong'an Pharmaceutical Nifedipine API Product Portfolio
  66. 8.11.5 Zhong'an Pharmaceutical Recent Developments
  67. 8.12 Yantai Luyin Pharmaceutical
  68. 8.12.1 Yantai Luyin Pharmaceutical Company Information
  69. 8.12.2 Yantai Luyin Pharmaceutical Business Overview
  70. 8.12.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio
  72. 8.12.5 Yantai Luyin Pharmaceutical Recent Developments
  73. 8.13 Qingyang Pharmaceutical
  74. 8.13.1 Qingyang Pharmaceutical Company Information
  75. 8.13.2 Qingyang Pharmaceutical Business Overview
  76. 8.13.3 Qingyang Pharmaceutical Nifedipine API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Qingyang Pharmaceutical Nifedipine API Product Portfolio
  78. 8.13.5 Qingyang Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine API Value Chain Analysis
  2. 9.1.1 Nifedipine API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine API Production Mode & Process
  6. 9.2 Nifedipine API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine API Distributors
  9. 9.2.3 Nifedipine API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst